
This episode discusses the FASTEST trial comparing Recombinant Factor VIIa to placebo for treating spontaneous intracerebral hemorrhage within two hours of onset.
ACCP EM PRN: June 2026 Article: https://pubmed.ncbi.nlm.nih.gov/41653933/ Presenter: Madelyn Johnson, PharmD, MBA | PGY2 Emergency Medicine Pharmacy Resident | Mayo Clinic Copyright Notice: By accessing this podcast, you understand and acknowledge that its contents and materials are the property of ACCP and the Emergency Medicine PRN. Further, the podcast, its contents and its materials are protected under United States and international copyright and trademark law. You understand that the podcast, its contents or materials are to be used only for personal or non-commercial purposes. Limitation of Liability; ACCP AND THE EMERGENCY MEDICINE PRN DISCLAIM ANY AND ALL LIABILITY OR RESPONSIBILITY FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR ANY OTHER DAMAGES, INCLUDING WITHOUT LIMITATION, LOSS OF PROFITS, ARISING OUT OF ANY USE OF, REFERENCE TO, RELIANCE ON, OR INABILITY TO USE THE PODCAST, ITS CONTENTS AND MATERIALS. Produced by Christian Kroll, PharmD, BCPS
Host: Christian Kroll
Guests: Madelyn Johnson, PharmD, MBA, Madelyn Johnson
Organizations: Mayo Clinic, ACCP, Emergency Medicine PRN
Books & works: Recombinant Factor VIIa vs Placebo for Spontaneous ICH Within 2 Hours of Onset: The FASTEST Trial
Explore listener stats, chart rankings, contacts and more on the The Code Tray: The ACCP Emergency Medicine PRN Podcast podcast page.